William Blair & Company’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $312K | Sell |
|
|||||
|
2025
Q1 | $289K | Buy |
|
|||||
|
2024
Q4 | $248K | Buy |
|
|||||
|
2024
Q3 | $185K | Sell |
|
|||||
|
2024
Q2 | $171K | Buy |
|
|||||
|
2024
Q1 | $147K | Sell |
|
|||||
|
2023
Q4 | $109K | Sell |
|
|||||
|
2023
Q3 | $111K | Buy |
|
|||||
|
2023
Q2 | $81.1K | Sell |
|
|||||
|
2023
Q1 | $95.5K | Buy |
|
|||||
|
2022
Q4 | $98K | Sell |
|
|||||
|
2022
Q3 | $89K | Sell |
|
|||||
|
2022
Q2 | $111K | Hold |
|
|||||
|
2022
Q1 | $138K | Sell |
|
|||||
|
2021
Q4 | $137K | Sell |
|
|||||
|
2021
Q3 | $179K | Hold |
|
|||||
|
2021
Q2 | $182K | Sell |
|
|||||
|
2021
Q1 | $218K | Sell |
|
|||||
|
2020
Q4 | $190K | Sell |
|
|||||
|
2020
Q3 | $401K | Sell |
|
|||||
|
2020
Q2 | $573K | Sell |
|
|||||
|
2020
Q1 | $419K | Buy |
|
|||||
|
2019
Q4 | $443K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $1.5M | Sell |
|
|||||
|
2018
Q4 | $1.81M | Buy |
|
|||||
|
2018
Q3 | $2.08M | Buy |
|
|||||
|
2018
Q2 | $1.44M | Sell |
|
|||||
|
2018
Q1 | $1.13M | Sell |
|
|||||
|
2017
Q4 | $1.27M | Sell |
|
|||||
|
2017
Q3 | $1.37M | Buy |
|
|||||
|
2017
Q2 | $2.58M | Buy |
|
|||||
|
2017
Q1 | $2.63M | Buy |
|
|||||
|
2016
Q4 | $308K | Sell |
|
|||||
|
2016
Q3 | $494K | Sell |
|
|||||
|
2016
Q2 | $1.2M | Sell |
|
|||||
|
2016
Q1 | $1.53M | Sell |
|
|||||
|
2015
Q4 | $2.23M | Sell |
|
|||||
|
2015
Q3 | $5.8M | Sell |
|
|||||
|
2015
Q2 | $323M | Sell |
|
|||||
|
2015
Q1 | $344M | Buy |
|
|||||
|
2014
Q4 | $283M | Buy |
|
|||||
|
2014
Q3 | $263M | Buy |
|
|||||
|
2014
Q2 | $13.8M | Sell |
|
|||||
|
2014
Q1 | $14.1M | Sell |
|
|||||
|
2013
Q4 | $19.8M | Buy |
|
|||||
|
2013
Q3 | $12.1M | Buy |
|
|||||
|
2013
Q2 | $12.2M | Buy |
|